Real-time enrollment status for this cancer clinical trial
Current Status
Recruiting
Checked: October 19, 2026 at 9:45 PM UTC
| NCT Number | NCT05203172 |
| Recruiting Status | Recruiting |
| Condition | Cancer |
| Phase | PHASE4 |
| Target Enrollment | 210 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | October 19, 2026 (21 hours ago) |
As of October 19, 2026: Clinical trial NCT05203172 is currently recruiting participants. This phase4 study for cancer is actively seeking new participants at 18 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05203172 is actively recruiting participants as of October 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05203172 was last updated 21 hours ago (October 19, 2026). HelloStudys verifies this status automatically.